Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee
Go back to Biogen (BIIB) Could Be Worth $375-475/Share in a Takeover - RBC Capital's Yee| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 215.50 -3.55 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.05 | 52 Week High | $333.65 | |||
| Open | $219.05 | 52 Week Low | $223.02 | |||
| Day High | $220.17 | P/E | 27.59 | |||
| Day Low | $215.26 | EPS | $7.81 | |||
| Volume | 2,635,886 | |||||
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.94 -1.14 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.08 | 52 Week High | $108.96 | |||
| Open | $65.25 | 52 Week Low | $62.12 | |||
| Day High | $65.29 | P/E | N/A | |||
| Day Low | $63.84 | EPS | $-1.27 | |||
| Volume | 4,455,960 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 146.87 -0.28 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.15 | 52 Week High | $65.46 | |||
| Open | $147.08 | 52 Week Low | $47.97 | |||
| Day High | $147.84 | P/E | 99.91 | |||
| Day Low | $145.74 | EPS | $1.47 | |||
| Volume | 31,159,364 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 508.34 -8 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $516.34 | 52 Week High | $134.71 | |||
| Open | $516.34 | 52 Week Low | $73.31 | |||
| Day High | $518.10 | P/E | N/A | |||
| Day Low | $505.01 | EPS | $-1.98 | |||
| Volume | 2,434,829 | |||||
